Interview 28 Jun 2017 Video: The Next Big Thing in Biotech according to Sofinnova’s Antoine Papiernik Antoine Papiernik, Managing Partner at the famous European biotech VC Sofinnova, closed Refresh this year with a keynote on the next big thing in biotech. Papiernik has more than 20 years of experience as a VC investor and has helped build major European biotechs like Actelion, ProQR or Movetis. Being part of the leading edge […] June 28, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2017 Danish Biotech Reports Positive Phase II data for a Common Cold Vaccine Bavarian Nordic has announced positive Phase II results for its universal vaccine against the common cold virus, RSV, which can be deadly for the elderly. The respiratory syncytial virus (RSV) is one of the perpetrators behind the common cold. For most, the virus just leads to a few uncomfortable days or weeks. But for children […] June 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2017 UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic Update (28/06/2017): Cellectis has announced the first administration of UCART123 in its Phase I trial in Acute Myeloid Leukemia. Update (07/02/2017): the FDA has granted Cellectis IND approval to start clinical trials with UCART123. Original publication 04/01/2017 Cellectis is preparing to start the first clinical trial ever using an allogeneic CAR-T therapy that could reduce […] June 28, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2017 A Spanish Vaccine to fight Alzheimer’s Before Symptoms Appear enters Phase II Araclon Biotech will advance to Phase II with an Alzheimer’s vaccine that could succeed where many others have failed before. Araclon Biotech, in Zaragoza, Spain, has announced today the approval from the Spanish Agency of Medicines and Medical Devices to start a Phase II trial testing its Alzheimer’s vaccine in 120 patients in 22 centers across Europe. The […] June 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 27 Jun 2017 Green Biotech Enters Partnership to Advance the Infinite Recycling of Plastics Carbios has teamed up with TechnipFMC in order to move Carbios’ enzymatic recycling process for PET plastics from the laboratory to the pilot scale. French Carbios is looking to combat the limits of current thermo-mechanical recycling processes using an enzyme-based degradation process that paves the way to infinite recycling of PET. The annual production of PET, one […] June 27, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jun 2017 Videos: Who won the Refresh Early-Stage Startup Battle? The Bonsai goes to… As you might have read in our recap, we had not one but two startup battles for the last edition of Refresh. Watch the companies’ pitches below! Up first was Cambridge Cancer Genomics, which uses AI to design personalised DNA-based tests to help clinicians to better track their patients’ responses to cancer drugs in order to make […] June 26, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jun 2017 New Belgian Biotech will use Microorganisms to Replace Pesticides and Fertilizers Aphea.Bio has gathered a total of €9M in funding to start working on a new technology to produce biopesticides and biostimulants for European agriculture. Belgium has a new biotech that will be dedicated to developing sustainable, microorganism-based biopesticides and biostimulants. Aphea.Bio has raised €7.7M in a Series A round led by the Belgian life sciences investor V-Bio Ventures in addition to a €1.3M grant […] June 26, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 26 Jun 2017 Meet the Gynecologist at the Helm of Geneva’s Star Biotech Ernest Loumaye began as a doctor at a university hospital and is now CEO of ObsEva. We chatted about how biotech supports women’s health. ObsEva, one of the top biotechs in Geneva that made this year’s first IPO for a huge €90M, is not Ernest Loumaye’s first company. Though he began as the gynecologist in charge of the reproductive […] June 26, 2017 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2017 Diabetic Patients that Still Produce Insulin might be the Key to a New Therapy A study from Uppsala University has identified higher levels of interleukin-35 in type 1 diabetics that still produce insulin years after their diagnosis. Researchers at Uppsala University have published the first study in humans that shows the potential of interleukin-35 (IL-35) as a promising new target to treat type 1 diabetes. The results, published in […] June 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 23 Jun 2017 French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch of its gene therapy for blindness in Europe and the US. Gensight has decided to give an additional financial push to its lead candidate, GS010, a gene therapy to restore sight in patients with the rare genetic disease Leber hereditary optic […] June 23, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 23 Jun 2017 This Newly Founded French Biotech is All About Vaccines This week we visited the biotech hub Lyon, where one of our top biotechs Imaxio has recently founded Osivax to advance the development of its innovative vaccine candidates. Mission: Osivax was formed as a spin-off of Imaxio’s R&D department and develops a number of clinical and preclinical vaccine candidates based on its OligoDOM technology. This approach fuses specific immunogenic domains to […] June 23, 2017 - 1 minutemin - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jun 2017 French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy Noble Généthon has teamed up with ignominious Sarepta to develop a gene therapy for the Duchenne variety of the muscle wasting disease. Dedicated to rare diseases since 1990 and more recently to gene therapy, Généthon is one of very few not-for-profit companies in European biotech. Though it has not yet brought a drug to market, it is […] June 22, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email